Author: Kelly Casey
You’re Invited: UVA-Hosted Virtual Symposium on Latest in Lung Cancer Management
UVA Health lung cancer specialists will discuss the latest developments in lung cancer management. Bring your questions.
What If We Could Detect Postpartum Depression With a Blood Test?
A UVA Health researcher has found definitive answers on risk factors for postpartum depression. And is laying the groundwork for a blood test for PPD.
Enhanced Cystoscopy & Innovative Practice Model Minimizes Bladder Cancer Recurrence
Blue light cystoscopy better pinpoints bladder cancer and improves access to life-saving surveillance after diagnosis.
UVA Health Customizes Type 1 Diabetes Therapy for More Effective Outcomes
UVA's Center for Diabetes Technology pioneers technology and analytics to improve glycemic control in people with type 1 diabetes.
UVA Health Pioneered an Imaging Tool Set to Revolutionize How We Diagnose Pulmonary Diseases
As the world’s leader in clinical research of hyperpolarized MRI, UVA is ushering in a new era of diagnostic advancement for pulmonary diseases.
An Unhealthy Gut May Contribute to Metastatic Breast Cancer, UVA Health Research Finds
This groundbreaking animal-model research moves us closer to understanding why GI health plays a key role in treating breast cancer.
UVA Pulmonology Achieves Impressive CF Patient Outcomes After Transitioning to Telehealth
UVA Adult Cystic Fibrosis Clinic caught the nation’s attention for its successful and quick transition to telehealth.
UVA Researchers Share Key Hematologic Malignancy Insights at National Meeting
Find out why lymphoma and leukemia patients can mount a protective immune response to coronavirus and other findings from UVA Health experts.
UVA Pulmonologist Unleashes Precision Medicine to Combat Pulmonary Fibrosis
Imre Noth, MD, helped secure $22 million in NIH and private funding to dramatically alter how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated.
UVA Pulmonology Takes National Lead in Understanding Pandemic’s Toll
UVA pulmonologists established one of the nation's first post-COVID clinics and brings valuable insights into COVID’s longterm toll by tying clinical data to blood biomarkers.